Suppr超能文献

吲哚美辛所致致命性再生障碍性贫血——体外淋巴细胞转化试验

Fatal aplastic anemia due to indomethacin--lymphocyte transformation tests in vitro.

作者信息

Schattner A, Shtalrid M, Levy R, Berrebi A

出版信息

Isr J Med Sci. 1981 Jun;17(6):433-6.

PMID:7263204
Abstract

Although indomethacin has been implicated as a possible cause of aplastic anemia on the basis of a few clinical observations, its role has not been definitely established. A case of fatal aplastic anemia is described in which no drugs other than allopurinol and indomethacin were given. Indomethacin was first given four weeks prior to the onset of symptoms. A positive lymphocyte transformation test with indomethacin in vitro further substantiates the potential role of this drug in causing aplastic anemia in a susceptible patient. Fortunately, this seems to be a very rare complication.

摘要

尽管基于一些临床观察,吲哚美辛被认为可能是再生障碍性贫血的一个病因,但其作用尚未明确确立。本文描述了一例致命性再生障碍性贫血病例,该患者除别嘌醇和吲哚美辛外未使用其他药物。吲哚美辛在症状出现前四周首次使用。体外吲哚美辛淋巴细胞转化试验呈阳性,进一步证实了该药物在易感患者中导致再生障碍性贫血的潜在作用。幸运的是,这似乎是一种非常罕见的并发症。

相似文献

2
[Bone marrow aplasia: a rare complication in virus-induced hepatitis].
Dtsch Z Verdau Stoffwechselkr. 1987;47(2):53-8.
9
Acquired aplastic anemia secondary to perphenazine.
Can J Clin Pharmacol. 1999 Autumn;6(3):169-71.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验